Ultra Clean Holdings, Inc.
UCTT
$100.91
+11.16%
Ultra Clean Holdings, Inc. manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry, including precision robotic solutions, gas delivery systems, and wafer cleaning subsystems. It is a key supplier to major semiconductor equipment makers, positioning itself as a critical enabler of chip manufacturing technology. The stock has surged over 326% in the past year, driven by the AI and semiconductor boom, but recent volatility after a sharp pullback from its 52-week high has sparked debate about whether the rally is sustainable or overextended.…
UCTT
Ultra Clean Holdings, Inc.
$100.91
Investment Opinion: Should I buy UCTT Today?
Rating: Hold. The thesis is that UCTT's extreme valuation discount (forward P/S 0.26) is offset by deteriorating fundamentals and high execution risk. The single analyst consensus is Buy, but without a price target, the implied upside is unclear. The stock is a speculative play on a semiconductor recovery that has not yet materialized.
Supporting Evidence: The primary valuation metric, forward P/S of 0.26, is a deep discount to the industry average of ~3.0, but this relies on revenue estimates of $4.55B that imply 224% growth. Revenue is currently declining (-10.1% YoY), and the company is unprofitable with a net margin of -0.7%. Free cash flow is barely positive at $14.7M TTM. The stock's 326% one-year gain already prices in a recovery, leaving little room for error. The trailing P/S of 2.33 is below the historical average, but this is justified by weak earnings.
Risks & Conditions: The biggest risks are (1) failure to achieve the estimated revenue rebound, (2) continued margin compression, and (3) a market correction that compresses growth stock multiples. This Hold would upgrade to Buy if the company reports a quarter with positive net income and revenue growth above 10% YoY, or if the forward P/S drops below 0.2. It would downgrade to Sell if revenue continues to decline sequentially or if gross margin falls below 14%. Currently, the stock appears overvalued relative to its fundamentals but undervalued on a forward basis if the recovery materializes — a classic value trap risk.
Sign up to view all
UCTT 12-Month Price Forecast
The AI assessment leans bearish due to the disconnect between the stock's price and the company's fundamental trajectory. While the forward valuation appears cheap, the current revenue decline and losses suggest that the expected recovery is far from certain. The single analyst estimate adds risk, and the stock's high beta makes it vulnerable to market downturns. A more favorable stance would require evidence of a revenue inflection, such as a quarter with positive YoY growth and improving margins. Until then, the risk/reward is skewed to the downside.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ultra Clean Holdings, Inc.'s 12-month outlook, with a consensus price target around $131.18 and implied upside of +30.0% versus the current price.
Average Target
$131.18
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$81 - $131
Analyst target range
Only 1 analyst covers UCTT, with a consensus Buy rating. The average EPS estimate for the current fiscal year is $7.99, with a low of $7.62 and high of $8.44. Revenue estimates average $4.55 billion, implying a massive rebound from the current run rate. The implied upside from the current price of $106.48 to the average target (not provided directly) cannot be calculated, but the strong EPS estimates suggest optimism. The limited coverage (1 analyst) means the stock has low institutional visibility, typical for a small-cap name. This can lead to higher volatility and less efficient price discovery. The analyst community appears bullish, with recent ratings from TD Cowen, Needham, and Oppenheimer all maintaining Buy or Outperform ratings. However, the lack of a price target range makes it difficult to gauge conviction. The wide range in EPS estimates ($7.62 to $8.44) indicates some uncertainty about the pace of recovery.
Bulls vs Bears: UCTT Investment Factors
Ultra Clean Holdings presents a high-risk, high-reward opportunity. The bull case rests on an anticipated massive revenue rebound driven by AI semiconductor spending, reflected in an extremely low forward P/S of 0.26. However, the bear case highlights that current revenue is declining, the company is unprofitable, and the valuation depends on unproven analyst estimates from a single covering analyst. The stock's 326% one-year gain and high beta suggest momentum-driven pricing that could reverse sharply if growth fails to materialize. The central tension is whether the semiconductor cycle will deliver the expected recovery in time to justify the current price, or if the company's operational challenges will persist, leading to a correction. Currently, the bearish evidence from deteriorating fundamentals outweighs the speculative bull case, making the stock a Hold with significant caveats.
Bullish
- Massive Revenue Rebound Expected: Analysts estimate FY2026 revenue of $4.55B, implying a 224% increase from the current run rate of ~$2.03B (annualized Q4 2025 revenue of $506.7M). This expectation is driven by the AI-driven semiconductor capex cycle, positioning UCTT as a key supplier to equipment makers like Applied Materials and Lam Research.
- Extremely Low Forward P/S Ratio: The forward P/S ratio is approximately 0.26, based on the current market cap of $1.18B and estimated revenue of $4.55B. This is a deep value multiple compared to the semiconductor industry average P/S of ~3.0, suggesting massive upside if revenue materializes.
- Strong Liquidity and Low Debt: The current ratio of 3.19 indicates strong short-term liquidity, with current assets covering liabilities more than three times. Debt-to-equity of 1.14 is moderate, and the company has manageable interest expense of $8.4M per quarter against operating income of $10.9M.
- Powerful Long-Term Momentum: The stock has gained 326% over the past year, massively outperforming the S&P 500's 19.1% return. The 6-month relative strength vs. SPY is +280.7%, indicating sustained institutional accumulation and strong technical momentum.
Bearish
- Revenue Declining, Not Growing: Q4 2025 revenue of $506.7M was down 10.1% year-over-year from $563.3M in Q4 2024. The multi-quarter trend shows sequential declines from $518.8M in Q2 2025 to $506.7M in Q4 2025, contradicting the narrative of a near-term recovery.
- Unprofitable with Negative Margins: The company reported a net loss of $3.3M in Q4 2025 and a trailing twelve-month net loss. Gross margin contracted to 15.3% from 16.3% a year ago, and net margin is -0.7%. ROE is -25.5%, reflecting poor capital efficiency.
- Extreme Valuation Relies on Unproven Estimates: The forward P/S of 0.26 depends on analysts' revenue estimate of $4.55B, which implies a 224% increase from current levels. With only 1 analyst covering the stock, the estimate has low conviction and could be overly optimistic.
- High Beta and Sharp Pullback Risk: With a beta of 1.834, the stock is 83% more volatile than the market. It recently dropped from $142.59 to $106.48 in a few days, a -25% decline, indicating high downside risk. The 52-week range of $21.28 to $144.22 shows potential for severe drawdowns.
UCTT Technical Analysis
The stock is in a powerful long-term uptrend, with a 1-year price change of +326.4%, massively outperforming the S&P 500's +19.1%. The current price of $106.48 sits at 73.8% of its 52-week range ($21.28 to $144.22), indicating it is still in the upper half but has pulled back from the highs. This positioning suggests strong momentum but also potential overextension after a parabolic move. Short-term momentum shows a 1-month change of +18.0% and a 3-month change of +68.6%, both accelerating relative to the longer-term trend. The 1-month relative strength vs. SPY is +19.3%, confirming strong near-term buying pressure. However, the stock recently dropped from $142.59 to $106.48 in just a few days, signaling a sharp pullback that could be a temporary correction or the start of a deeper reversal. The 52-week high of $144.22 acts as key resistance; a breakout above that level would signal a continuation of the uptrend. The 52-week low of $21.28 provides major support, but the stock is far above that. Beta of 1.834 indicates the stock is 83.4% more volatile than the market, meaning larger swings and higher risk for position sizing.
Beta
1.83
1.83x market volatility
Max Drawdown
-36.3%
Largest decline past year
52-Week Range
$21-$144
Price range past year
Annual Return
+304.9%
Cumulative gain past year
| Period | UCTT Return | S&P 500 |
|---|---|---|
| 1m | +20.2% | +0.8% |
| 3m | +38.7% | +9.6% |
| 6m | +195.0% | +7.4% |
| 1y | +304.9% | +20.2% |
| ytd | +269.4% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
UCTT Fundamental Analysis
Revenue in the most recent quarter (Q4 2025) was $506.7 million, down 10.1% year-over-year from $563.3 million in Q4 2024. The multi-quarter trend shows deceleration: revenue fell from $518.8M in Q2 2025 to $506.7M in Q4 2025, with the Products segment contributing $442.4M and Services $64.2M. The declining revenue raises concerns about demand in the semiconductor cycle, though the long-term AI-driven capex cycle may provide a tailwind. The company is unprofitable, with net income of -$3.3 million in Q4 2025 and a trailing twelve-month net loss. Gross margin was 15.3% in Q4 2025, down from 16.3% in Q4 2024, indicating margin compression. Operating margin was 2.2%, barely positive, and net margin was -0.7%, reflecting high costs relative to revenue. The balance sheet shows a current ratio of 3.19, indicating strong liquidity, but debt-to-equity of 1.14 suggests moderate leverage. Free cash flow was -$2.6 million in Q4 2025, and trailing twelve-month FCF was $14.7 million, barely positive. ROE is -25.5%, reflecting poor returns on equity. The company generates enough cash to cover operations but not to fund significant growth internally.
Quarterly Revenue
$506700000.0B
2025-12
Revenue YoY Growth
-0.10%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$14700000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is UCTT Overvalued?
Since net income is negative (TTM net loss), the trailing P/E of -6.51 is not meaningful. Therefore, we use the price-to-sales (P/S) ratio as the primary valuation metric. The trailing P/S is 2.33, while the forward P/S (based on estimated revenue of $4.55B) is approximately 0.26, implying a massive drop in valuation multiple due to expected revenue growth. This gap suggests the market anticipates a sharp revenue recovery. Compared to the semiconductor industry average P/S of roughly 3.0 (estimated), UCTT's trailing P/S of 2.33 is at a 22% discount, but the forward P/S of 0.26 is extremely low, indicating deep value if revenue estimates materialize. Historically, the stock's P/S has ranged from about 1.6 to 5.5 over the past five years. The current trailing P/S of 2.33 is near the lower end of that range, suggesting the stock is relatively cheap compared to its own history. This could indicate a value opportunity if the company's growth reaccelerates, but it also reflects the current earnings weakness.
PE
-6.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -196x~33x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-53.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: UCTT faces significant financial risks from declining revenue and persistent losses. Revenue fell 10.1% YoY to $506.7M in Q4 2025, and the company reported a net loss of $3.3M for the quarter. Gross margin contracted to 15.3% from 16.3% a year ago, while operating margin is a razor-thin 2.2%. Free cash flow was negative -$2.6M in Q4 2025, and trailing twelve-month FCF of $14.7M is barely positive. With a debt-to-equity ratio of 1.14, the company has moderate leverage, but negative ROE of -25.5% indicates poor returns on equity. The company's reliance on a single cyclical industry (semiconductor capital equipment) amplifies earnings volatility, and the current revenue trajectory does not support the valuation.
Market & Competitive Risks: The stock's valuation is extremely stretched, with a trailing P/S of 2.33 that is near the low end of its historical range (1.6-5.5), but this reflects current earnings weakness. The forward P/S of 0.26 implies a massive revenue recovery that may not materialize. With a beta of 1.834, the stock is highly sensitive to market downturns and sector rotation. The semiconductor industry is cyclical, and any slowdown in AI-related capex could lead to multiple compression. The stock's 326% one-year gain makes it vulnerable to profit-taking, as evidenced by the recent -25% pullback from $142.59 to $106.48. Limited analyst coverage (only 1 analyst) reduces price discovery and increases information risk.
Worst-Case Scenario: In a severe downturn, UCTT could see its revenue continue to decline if the semiconductor cycle turns down, leading to further losses and cash burn. The stock could retest its 52-week low of $21.28, representing a -80% decline from the current price of $106.48. This scenario would be triggered by a broader tech sell-off, a sharp reduction in AI capex, or a failure to achieve the expected revenue rebound. The historical max drawdown of -29.74% (from recent highs) already shows the stock's vulnerability, but a full-cycle downturn could push it much lower.
FAQ
The key risks are: (1) Financial risk: Revenue is declining 10.1% YoY, the company is unprofitable with a net margin of -0.7%, and free cash flow is barely positive at $14.7M TTM. (2) Valuation risk: The stock's forward P/S of 0.26 depends on unproven analyst estimates from a single covering analyst, and any disappointment could lead to a sharp de-rating. (3) Market risk: With a beta of 1.834, the stock is highly volatile and recently experienced a -25% pullback from its high. (4) Competitive risk: As a supplier to semiconductor equipment makers, UCTT is exposed to cyclical downturns and potential loss of market share. The most severe risk is a -80% decline to the 52-week low if the recovery fails.
The 12-month outlook is uncertain, with three scenarios: (1) Bull case (20% probability): Revenue exceeds $4.5B, driving the stock to $140-$160. (2) Base case (50% probability): Revenue recovers to ~$3.5B, and the stock trades between $80 and $120. (3) Bear case (30% probability): Revenue stagnates around $2B, and the stock falls to $40-$70. The base case is most likely, assuming a modest semiconductor recovery. However, the current price of $106.48 is near the top of the base case range, suggesting limited upside. The key assumption is whether the company can return to revenue growth and profitability in the coming quarters.
UCTT's valuation presents a stark contrast between trailing and forward metrics. The trailing P/S of 2.33 is below the semiconductor industry average of ~3.0 and near the low end of its historical range (1.6-5.5), suggesting it is fairly valued based on current revenue. However, the forward P/S of 0.26 implies the stock is deeply undervalued if the estimated revenue of $4.55B materializes. This extreme gap reflects the market's skepticism about the recovery. The stock is overvalued relative to its current fundamentals (negative earnings, declining revenue) but could be undervalued on a forward basis if the growth story plays out. Investors are essentially paying for a recovery that has not yet started.
UCTT is a high-risk, high-reward stock that may appeal to aggressive investors with a long-term horizon. The forward P/S of 0.26 suggests deep value if the company achieves the estimated revenue of $4.55B, but current revenue is declining 10.1% YoY and the company is unprofitable. The single analyst consensus is Buy, but without a price target, the upside is uncertain. The biggest downside risk is that the expected recovery fails to materialize, potentially leading to a -80% decline to the 52-week low of $21.28. For conservative investors, it is not a good buy; for those willing to bet on a semiconductor cycle recovery, it could be a speculative position.
UCTT is more suitable for long-term investment (3-5 years) given its speculative nature and dependence on a cyclical recovery. The stock's high beta of 1.834 and recent volatility make it risky for short-term trading, as sharp pullbacks can occur. The company does not pay a dividend, so returns depend entirely on price appreciation. Long-term investors should be prepared for significant drawdowns, as the stock has a history of large swings. A minimum holding period of 3 years is recommended to allow time for the semiconductor cycle to turn. Short-term traders may find opportunities in momentum, but the risk of a -25% correction is high.